Focal Interest
Focal Interest

Drug

  1. Gut microbiome helps shape Parkinson’s drug interactions
    Drug-microbiome-drug interaction study reveals how COMT inhibitors used with levodopa alter gut bacteria and affect medication metabolism in Parkinson's patients.
  2. Microneedle biosensor tracked drug clearance and organ dysfunction
    Wearable microneedle biosensors with durable nanostructured electrodes continuously monitor drug clearance to detect liver and kidney dysfunction in real time.
  3. Most favored nation drug pricing may lower industry research revenue
    Analysis of most favored nation drug pricing as policy mechanism to reduce international price disparities and effects on pharmaceutical research investment and innovation.
  4. Indonesia drug death penalty framed as state violence
    Examination of Indonesia's death penalty for drug offences as necropolitical state violence, arguing judicial and extrajudicial punishment operate within the same continuum.
  5. Zuranolone was approved for postpartum depression, not major depressive disorder
    Analysis of zuranolone approval reveals how fast-track designations and reduced evidentiary thresholds in drug regulation may inadequately balance innovation with public health protection.
  6. Turkish drug recalls were driven by contamination, sterility, and safety issues
    Systematic analysis of 133 drug recalls by Turkish regulatory agency 2018-2024, identifying 14 recall reasons with Class A and B classifications predominating.
  7. Drug shortages create risks in obstetric care
    Clinical analysis of drug shortages in obstetric care addressing causation, prediction, and systematic response mechanisms for healthcare institutions.
  8. Meloxicam approval in cats is questioned over kidney risk and missing trial data
    Examine injectable meloxicam approval for cats, regulatory data discrepancies, acute kidney injury risks, and pharmaceutical sponsorship conflicts in veterinary medicine.
  9. PET/CT lesion profiles matched tuberculosis treatment outcomes in marmosets
    PET/CT-derived multivariate lesion profiles in M. tuberculosis–infected marmosets predict clinical regimen performance, distinguish cavitary granuloma responses, and outperform bacterial burden.